Skip to main content
PMC home page
Bacteriological Reviews logoLink to Bacteriological Reviews
. 1960 Mar;24(1):141–150. doi: 10.1128/br.24.1.141-150.1960

SERUM AND TISSUE INHIBITORS OF VIRUS

Harold S Ginsberg 1,2
PMCID: PMC441043  PMID: 13850232

Full text

PDF
144

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADAMS J. M., IMAGAWA D. T. Immunological relationship between measles and distemper viruses. Proc Soc Exp Biol Med. 1957 Oct;96(1):240–244. doi: 10.3181/00379727-96-23442. [DOI] [PubMed] [Google Scholar]
  2. ALLEN R., FINKELSTEIN R. A., SULKIN S. E. Viral inhibitors in normal animal sera. Tex Rep Biol Med. 1958;16(4):391–421. [PubMed] [Google Scholar]
  3. BANG F. B., FOARD M., KARZON D. T. Mode of action of heat labile serum inactivating substance on Newcastle disease virus. Bull Johns Hopkins Hosp. 1951 Jan;88(1):83–100. [PubMed] [Google Scholar]
  4. BLIX F. G., GOTTSCHALK A., KLENK E. Proposed nomenclature in the field of neuraminic and sialic acids. Nature. 1957 May 25;179(4569):1088–1088. doi: 10.1038/1791088b0. [DOI] [PubMed] [Google Scholar]
  5. BOGOCH S. Inhibition of viral hemagglutination by brain ganglioside. Virology. 1957 Dec;4(3):458–466. doi: 10.1016/0042-6822(57)90079-x. [DOI] [PubMed] [Google Scholar]
  6. BRIODY B. A., LEDINKO N., STANNARD C. Studies on vaccinia virus. II. Neutralization of vaccinia virus by normal guinea pig serum. J Immunol. 1951 Nov;67(5):413–422. [PubMed] [Google Scholar]
  7. BURNET F. M. Mucoproteins in relation to virus action. Physiol Rev. 1951 Apr;31(2):131–150. doi: 10.1152/physrev.1951.31.2.131. [DOI] [PubMed] [Google Scholar]
  8. CHU C. M. The action of normal mouse serum on influenza virus. J Gen Microbiol. 1951 Oct;5(4):739–757. doi: 10.1099/00221287-5-4-739. [DOI] [PubMed] [Google Scholar]
  9. COHEN A., BELYAVIN G. Hemagglutination inhibition of Asian influenza viruses: a new pattern of response. Virology. 1959 Jan;7(1):59–74. doi: 10.1016/0042-6822(59)90177-1. [DOI] [PubMed] [Google Scholar]
  10. COWAN K. M. Interpretation of properdin levels determined by phage neutralization technique. Science. 1958 Oct 3;128(3327):778–779. doi: 10.1126/science.128.3327.778. [DOI] [PubMed] [Google Scholar]
  11. Casals J., Olitsky P. K. Inactivation of Certain Neurotropic Viruses in Vitro by Serum Lipids. Science. 1947 Sep 19;106(2751):267–268. doi: 10.1126/science.106.2751.267. [DOI] [PubMed] [Google Scholar]
  12. Casals J., Olitsky P. K. Protection of Mice Against an Encephalitis Virus by Means of Organic-Solvent Extracts of Brain Tissue. Science. 1948 Dec 17;108(2816):690–691. doi: 10.1126/science.108.2816.690. [DOI] [PubMed] [Google Scholar]
  13. FINKELSTEIN R. A., ALLEN R., SULKIN S. E. Properdin sensitivity of herpes simplex virus. Virology. 1958 Jun;5(3):567–568. doi: 10.1016/0042-6822(58)90046-1. [DOI] [PubMed] [Google Scholar]
  14. GELLER P., COLEMAN V. R., JAWETZ E. Studies on herpes simplex virus. V. The fate of viable herpes simplex virus administered intravenously to man. J Immunol. 1953 Dec;71(6):410–418. [PubMed] [Google Scholar]
  15. GINSBERG H. S. Characteristics of the new respiratory viruses (adenoviruses). I. Qualitative and quantitative aspects of the neutralization reaction. J Immunol. 1956 Oct;77(4):271–278. [PubMed] [Google Scholar]
  16. GINSBERG H. S., PILLEMER L., WEDGWOOD R. J. The properdin system and immunity. VI. The inactivation of Newcastle disease virus by the properdin system. J Exp Med. 1956 Nov 1;104(5):707–725. doi: 10.1084/jem.104.5.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. GOTTSCHALK A. N-substituted isoglucosamine released from mucoproteins by the influenza virus enzyme. Nature. 1951 May 26;167(4256):845–847. doi: 10.1038/167845a0. [DOI] [PubMed] [Google Scholar]
  18. HINZ C. F., Jr, JORDAN W. S., Jr, PILLEMER L. The properdin system and immunity. IV. The hemolysis of erythrocytes from patients with paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1956 May;35(5):453–457. doi: 10.1172/JCI103296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. HOLLAND J. J., McLAREN L. C. The mammalian cell-virus relationship. II. Adsorption, reception, and eclipse of poliovirus by HeLa cells. J Exp Med. 1959 May 1;109(5):487–504. doi: 10.1084/jem.109.5.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. HOWE C., ROSE H. M., SCHNEIDER L. Enzymic action of influenza virus on human erythrocyte stroma components. Proc Soc Exp Biol Med. 1957 Oct;96(1):88–94. doi: 10.3181/00379727-96-23401. [DOI] [PubMed] [Google Scholar]
  21. KLEIN M. The significance of human antiviral neutralizing substances in animal sera. Ann N Y Acad Sci. 1958 Jun 3;70(3):362–368. doi: 10.1111/j.1749-6632.1958.tb35394.x. [DOI] [PubMed] [Google Scholar]
  22. KLENK E., LEMPFRID H. Uber die Natur der Zellreceptoren für das Influenzavirus. Hoppe Seylers Z Physiol Chem. 1957;307(2-6):278–283. [PubMed] [Google Scholar]
  23. LEDINKO N., MELNICK J. L. Poliomyelitis viruses in tissue culture. V. Reaction of virus and antibody; variables of the quantitative neutralization test. Am J Hyg. 1953 Sep;58(2):223–247. [PubMed] [Google Scholar]
  24. LEPOW I. H., PILLEMER L., SCHOENBERG M. D., TODD E. W., WEDGWOOD R. J. The properdin system and immunity. X. Characterization of partially purified human properdin. J Immunol. 1959 Oct;83:428–436. [PubMed] [Google Scholar]
  25. MANDEL B., RACKER E. Inhibition of Theiler's encephalomyelitis virus (GDVII strain) of mice by an intestinal mucopolysaccharide. I. Biological properties and mechanism of action. J Exp Med. 1953 Nov;98(5):399–415. doi: 10.1084/jem.98.5.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. MANDEL B., RACKER E. Inhibition of Theiler's encephalomyelitis virus (GDVII strain) of mice by an intestinal mucopolysaccharide. II. Purification and properties of the mucopolysaccharide. J Exp Med. 1953 Nov;98(5):417–426. doi: 10.1084/jem.98.5.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. MCCARTHY K., GERMER W. D. Two heat-labile factors in normal sera which neutralize variola virus. Br J Exp Pathol. 1952 Dec;33(6):529–536. [PMC free article] [PubMed] [Google Scholar]
  28. NELSON R. A., Jr An alternative mechanism for the properdin system. J Exp Med. 1958 Oct 1;108(4):515–535. doi: 10.1084/jem.108.4.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. NOLL H., YOUNGNER J. S. Virus-lipid interactions. II. The mechanism of adsorption of lipophilic viruses to water-insoluble polar lipids. Virology. 1959 Jul;8(3):319–343. doi: 10.1016/0042-6822(59)90033-9. [DOI] [PubMed] [Google Scholar]
  30. PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
  31. PILLEMER L., HINZ C. F., Jr, WURZ L. Preparation and properties of antihuman properdin rabbit serum. Science. 1957 Jun 21;125(3260):1244–1245. doi: 10.1126/science.125.3260.1244. [DOI] [PubMed] [Google Scholar]
  32. SABIN A. B. The dengue group of viruses and its family relationships. Bacteriol Rev. 1950 Sep;14(3):225–232. [PubMed] [Google Scholar]
  33. SKARNES R. C., WATSON D. W. Antimicrobial factors of normal tissues and fluids. Bacteriol Rev. 1957 Dec;21(4):273–294. doi: 10.1128/br.21.4.273-294.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. TAMM I., HORSFALL F. L., Jr A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses. J Exp Med. 1952 Jan;95(1):71–97. doi: 10.1084/jem.95.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. TOUSSAINT A. J., MUSCHEL L. H. Neutralization of bacteriophage by normal serum. Nature. 1959 Jun 27;183:1825–1827. doi: 10.1038/1831825a0. [DOI] [PubMed] [Google Scholar]
  36. UTZ J. P. Studies on the inactivation of influenza and Newcastle disease viruses by a specific lipid fraction of normal animal sera. J Immunol. 1949 Nov;63(3):273–279. [PubMed] [Google Scholar]
  37. Van Vunakis H., Barlow J. L., Levine L. NEUTRALIZATION OF BACTERIOPHAGE BY THE PROPERDIN SYSTEM. Proc Natl Acad Sci U S A. 1956 Jul;42(7):391–394. doi: 10.1073/pnas.42.7.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. WARDLAW A. C., PILLEMER L. The properdin system and immunity. V. The bactericidal activity of the properdin system. J Exp Med. 1956 May 1;103(5):553–575. doi: 10.1084/jem.103.5.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. WEDGWOOD R. J., PILLEMER L. The nature and interactions of the properdin system. Acta Haematol. 1958 Jul-Oct;20(1-4):253–259. doi: 10.1159/000205491. [DOI] [PubMed] [Google Scholar]

Articles from Bacteriological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES